...
首页> 外文期刊>Кардиология >SELECTION OF PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION FOR THE CATHETER-BASED RENAL SYMPATHETIC DENERVATION
【24h】

SELECTION OF PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION FOR THE CATHETER-BASED RENAL SYMPATHETIC DENERVATION

机译:选择抗动脉高压患者的导管肾交感神经障碍

获取原文
获取原文并翻译 | 示例

摘要

Purpose: elaboration of algorithm for selection of patients with resistant arterial hypertension (AH) for Catheter-Based Renal Sympathetic Denervation (CBRSD). Materials and methods. We examined 284 patients with resistant AH. On stage 1 we excluded most frequent causes of secondary AH. In 247 patients (86.9 %) we established secondary character of AH, in 37 patients (13.1 %) AH was found to be essential. On stage 2 patients with essential AH were given 3-5 component hypotensive therapy. At the background of this therapy we conducted 24-hour ambulatory blood pressure monitoring (ABPM). CBRSD procedure was considered indicated if according to ABPM average 24-hour blood pressure (BP) was above 150 and 100 mm Hg, and 24-hour elevated BP load exceeded 60 %. In 13 of 37 patients (35 %) BP level satisfied these conditions. For CBRSD we used high frequency generator. Ablation was performed using the Symplicity Catheter. Results were assessed in 1, 2, 9, 12, and 28 months. Results. Target BP level at the background of minimal doses of hypotensive drugs was achieved in 11 patients (85 %), what was confirmed by ABPM data. Levels of mean 24-4 hour systolic and diastolic BP significantly decreased from 173.9 +/- 14.9 to 143 +/- 21.3,.< 0.05, and from 108.2 +/- 8.7 to 91.4 +/- 13.8 mm Hg., p < 0.05, respectively. Index of elevated systolic BP time decreased from 78.2 +/- 14.6 to 49.8 +/- 29.6 %,p < 0.05. Best effect was achieved in patients with AH duration before the procedure less than 7 years. None of the patients had episodes of cerebral vascular insufficiency or heart failure progression. Conclusion. While determining indications to bilateral CBRSD one should be governed by such criteria as exclusion of symptomatic AH and objective proofs of AH resistance (according to ABPM at the background of hypotensive therapy).
机译:目的:制定用于选择抗性动脉高压患者(AH)的患者对基于导管的肾交感神经去除(CBRSD)的算法。材料和方法。我们检查了284名抗性症患者。在第1阶段,我们排除了次要的最常见的原因啊。在247名患者中(86.9%)我们建立了α的二级特征,在37名患者中(13.1%)啊被发现至关重要。在2阶段2患有必需患者的患者3-5分组分低血压治疗。在此疗法的背景下,我们进行了24小时的动态血压监测(ABPM)。 CBRSD程序被认为是表示的,如果根据ABPM平均24小时血压(BP)高于150和100mm Hg,并且24小时升高的BP负载超过60%。在37名患者中的13例(35%)BP水平满足这些条件。对于CBRSD,我们使用了高频发生器。使用对称导管进行消融。结果在1,2,9,12和28个月内评估。结果。在11名患者中实现了最小剂量低血压药物的目标BP水平(85%),通过ABPM数据证实了什么。平均24-4小时的平均水平和舒张压率高的173.9 +/-14.9至143 +/- 21.3,。<0.05,108.2 +/- 8.7至91.4 +/- 13.8 mm Hg。,P <0.05 , 分别。收缩性BP时间升高的指数从78.2 +/- 14.6降至49.8 +/- 29.6%,P <0.05。在持续时间持续时间少于7年之前,在持续时间达到最佳效果。患者没有一系列脑血管功能不全或心力衰竭进展。结论。在确定双边CBRSD的适应症时,应由这种标准管辖,因为排除症状啊,艾哈降的客观证明(根据ABPM在低血压治疗的背景下)。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号